Literature DB >> 3243051

The diagnosis by computed tomography of brachial plexus lesions following radiotherapy for carcinoma of the breast.

J Cooke1, S Powell, C Parsons.   

Abstract

The region of the brachial plexus in the root of neck and axilla was examined by computed tomography (CT) in 62 patients attending the Royal Marsden Hospital. Forty-two of these patients had been treated by surgery and subsequent radiotherapy for carcinoma of the breast. Computed tomography was able to identify varying grades of abnormality that were ascribed to radiation fibrosis. Twenty-eight patients had neurological symptoms affecting the arm or hand on the treated side and CT changes were seen in 96%. The grading and significance of these CT abnormalities is discussed. The patients had been treated by two different radiotherapy techniques (three-field and four-field) which utilised either a large or small treatment fraction. The higher grades of abnormality on CT were seen in 57% of those treated with the large fraction size and 27% of those treated with the small fraction size. However, the changes on CT did not relate to the different radiotherapy techniques.

Entities:  

Mesh:

Year:  1988        PMID: 3243051     DOI: 10.1016/s0009-9260(88)80061-8

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  3 in total

1.  Management of breast cancer. Neurological symptoms may not be due to radiotherapy.

Authors:  I H Kunkler; U Chetty; A Rodger
Journal:  BMJ       Date:  1994-03-12

2.  Volumetric tumor burden and its effect on brachial plexus dosimetry in head and neck intensity-modulated radiotherapy.

Authors:  Paul B Romesser; Muhammad M Qureshi; Nataliya Kovalchuk; Minh Tam Truong
Journal:  Med Dosim       Date:  2014-01-27       Impact factor: 1.482

3.  Effective treatment of the brachial plexus syndrome in breast cancer patients by early detection and control of loco-regional metastases with radiation or systemic therapy.

Authors:  Boriana Kamenova; Albert S Braverman; Michael Schwartz; Chul Sohn; Christopher Lange; Daniel Efiom-Ekaha; Marvin Rotman; Harold Yoon
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.